Table 1.  .

Demographic and Ophthalmic Characteristics (n = 35)

Factor	Value
Age, y	55.8 ± 15.5
Sex, n (male)	22 (62.9%)
Ancestry, n
Caucasian	26 (74.3%)
Asian	5 (14.3%)
African American	1 (2.9%)
Hispanic	3 (8.8%)
Pseudophakia	3 (8.8%)
Visual field MD, dB	−1.5 ± 2.6
Visual field PST, dB	2.6 ± 1.9
Use of IOP-lowering drops, n	23 (65.7%)
PGA monotherapy	13 (37.1%)
CAI monotherapy	1 (2.9%)
Combination PGA–CAI	2 (5.7%)
Combination PGA + CAI–β-blocker	2 (5.7%)
Combination PGA + α-agonist–β-blocker	2 (5.7%)
Combination PGA–β-blocker	1 (2.9%)
Combination α-agonist–β-blocker	1 (2.9%)
Combination PGA + α-agonist–CAI	1 (2.9%)